The only terpene that directly activates cannabinoid receptors — a dietary cannabinoid.
Beta-caryophyllene is unique among terpenes: it is the only terpene known to directly bind to and activate CB2 cannabinoid receptors, making it a functional cannabinoid as well as a terpene. This gives it potent anti-inflammatory, analgesic, and neuroprotective properties without psychoactive effects. It is found in black pepper, cloves, and many culinary herbs.
Aroma Profile
Primary Effects
Also Found In
Black pepper, Cloves, Cinnamon, Basil
Caryophyllene is a selective CB2 agonist — the only dietary compound known to activate the endocannabinoid system. CB2 activation reduces neuroinflammation and produces analgesic effects without psychoactivity.
Inhibits nuclear factor kappa-B (NF-κB), a master regulator of inflammation, reducing production of pro-inflammatory cytokines including TNF-α, IL-1β, and IL-6.
Activates peroxisome proliferator-activated receptor gamma (PPAR-γ), contributing to anti-inflammatory and metabolic effects.
Interacts with mu and kappa opioid receptors, potentially contributing to analgesic effects and reducing opioid dependence in preclinical models.
Caryophyllene is the most pharmacologically active terpene. Its CB2 agonism adds a true cannabinoid-like anti-inflammatory effect to any cannabis product. It is particularly important in CBD-dominant products, where it amplifies anti-inflammatory and analgesic effects.
Chronic Pain
Strong EvidenceCB2 agonism produces analgesic effects without psychoactivity. Multiple preclinical studies and growing clinical evidence support its use for inflammatory pain.
Condition guideInflammation
Strong EvidencePotent anti-inflammatory via CB2 activation and NF-κB pathway inhibition. Reduces TNF-α, IL-1β, and IL-6 in multiple models.
Condition guideAnxiety
Moderate EvidenceCB2 receptor activation in the limbic system produces anxiolytic effects. Human observational data supports anxiety reduction.
Condition guideAddiction/SUD
Moderate EvidenceCB2 agonism reduces alcohol and cocaine self-administration in animal models. Early human data suggests potential for SUD treatment.
Condition guideNeurodegeneration
Preliminary EvidenceNeuroprotective via CB2-mediated reduction of neuroinflammation. Promising in Alzheimer's and Parkinson's preclinical models.
Condition guideBeta-caryophyllene is a dietary cannabinoid
Landmark study establishing beta-caryophyllene as a selective CB2 agonist, the first dietary compound shown to activate the endocannabinoid system.
Caryophyllene reduces alcohol self-administration via CB2
Beta-caryophyllene reduced alcohol self-administration by 50% in rodent models via CB2-dependent mechanism, suggesting potential for AUD treatment.
Anti-inflammatory effects of caryophyllene in human macrophages
Caryophyllene reduced LPS-induced TNF-α by 62% and IL-6 by 55% in human macrophages at concentrations achievable through cannabis consumption.
Neuroprotective effects of beta-caryophyllene in Alzheimer's models
Caryophyllene reduced amyloid-beta plaque formation by 35% and improved cognitive performance in APP/PS1 transgenic mice via CB2-mediated neuroinflammation reduction.
Girl Scout Cookies
Hybrid
Gelato
Hybrid
Sour Diesel
Sativa
Bubba Kush
Indica
Jealousy
Hybrid
GRAS status. No psychoactive effects. Safe at all cannabis concentrations. May interact with immunosuppressant medications via CB2 pathway.
All terpene information is for educational purposes only. Consult a healthcare provider before using cannabis therapeutically.